In accordance with CLIA Approved Guideline C28-A [7] the XYZ Research Laboratory will adopt the pediatric reference ranges contained in the tables on pages 2-7.
“The NCCLS Approved Guideline C28-A [7] describes different ways for a laboratory to validate the "transference" of established reference intervals to the individual laboratory:
1. Divine judgment. The acceptability of the transfer may be subjectively assessed on the basis of consistency between the "demographics and geographics" of the study population(s) and the demographics of the laboratory's test population(s). The laboratory simply reviews the information submitted and subjectively verifies that the reference intervals are applicable to the adopting laboratory's patient population and test methods. To do this, all the information about the original study should be requested and made available to the adopting laboratory. This includes the demographics of the reference sample group, the selection process, pre-analytical conditions of the study such as subject preparation and specimen collection and handling techniques, the analytical system used, and the statistical method used to establish the intervals. Sometimes it is useful to request the original reference values and to re-analyze them to verify the original statistical analysis. Most cases for transference involve adoption of intervals from another laboratory using the same analytical system or intervals established by the method manufacturer.
US CLIA regulations permit the Medical Director of a laboratory to make this assessment and judgment.
While transference requires only the appropriate signature, the approach depends on a careful investigation of published recommendations, access to appropriate information, and significance laboratory and medical experience to assure the comparability of conditions.
Provision of reference intervals for sub-populations, particularly the pediatrics year-by-year intervals, often requires this approach because of the difficulty in obtaining sufficient specimens to experimentally establish or verify reference intervals.”
The adoption of these ranges is based on sound clinical judgment and consultation with local medical professionals, including pediatricians. The reference ranges are judged to be representative of the XYZ population demographics and geographical conditions. These ranges will be monitored and verified over time when appropriate data becomes available.
Test | Age | Reference Range | Critical Values | Source | Comments |
---|---|---|---|---|---|
CD4%- | 0-30 days | 18 – 17 | Critical values based on absolute cell counts | Ugandan | |
31-365 days | 15 – 6 | Ugandan | |||
366-730 days | 18 – 60 | Ugandan | |||
2-5 years | 23 – 48 | JHU-Harriet Lane Ref.-6th Ed | |||
6-10 years | 27 – 53 | JHU-Harriet Lane Ref.-6th Ed | |||
11-16 years | 25 – 48 | JHU-Harriet Lane Ref.-6th Ed | |||
CD4ABS, cells/uL | 0-30 days | 400 – 3600 | <200 cells/uL | Ugandan | Range verified locally |
31-365 days | 500 – 3800 | Ugandan | Range verified locally | ||
366-730 days | 400 – 3400 | Ugandan | Range verified locally | ||
2-5 years | 500 – 2400 | JHU-Harriet Lane Ref.-6th Ed | |||
6-10 years | 300 – 2000 | JHU-Harriet Lane Ref.-6th Ed | |||
11-16 years | 400 – 2100 | JHU-Harriet Lane Ref.-6th Ed | |||
CD8%- | 0-7 days | 10 – 41 | None | JHU-Harriet Lane Ref.-6th Ed | |
8-60 days | 9 – 28 | JHU-Harriet Lane Ref.-6th Ed | |||
61-270 days | 13 – 26 | JHU-Harriet Lane Ref.-6th Ed | |||
271-730 days | 11 – 32 | JHU-Harriet Lane Ref.-6th Ed | |||
2-5 years | 14 – 33 | JHU-Harriet Lane Ref.-6th Ed | |||
6-10 years | 19 – 34 | JHU-Harriet Lane Ref.-6th Ed | |||
11-16 years | 9 – 35 | JHU-Harriet Lane Ref.-6th Ed | |||
CD8ABS, cells/uL | 0-7 days | 200 – 1900 | None | JHU-Harriet Lane Ref.-6th Ed | Range verified locally |
8-60 days | 400 – 1700 | JHU-Harriet Lane Ref.-6th Ed | |||
61-270 days | 600 – 2200 | JHU-Harriet Lane Ref.-6th Ed | |||
271-730 days | 400 – 2300 | JHU-Harriet Lane Ref.-6th Ed | Range verified locally | ||
2-5 years | 300 – 1600 | JHU-Harriet Lane Ref.-6th Ed | |||
6-10 years | 300 – 1800 | JHU-Harriet Lane Ref.-6th Ed | |||
11-16 years | 200 – 1200 | JHU-Harriet Lane Ref.-6th Ed | |||
CD4CD8RT, ratio | 0-7 days | 1.0 – 2.6 | None | JHU-Harriet Lane Ref.-6th Ed | |
8-60 days | 1.3 – 6.3 | JHU-Harriet Lane Ref.-6th Ed | |||
61-270 days | 1.6 – 3.8 | JHU-Harriet Lane Ref.-6th Ed | |||
271-730 days | 0.9 – 3.7 | JHU-Harriet Lane Ref.-6th Ed | Range verified locally | ||
2-5 years | 0.9 – 2.9 | JHU-Harriet Lane Ref.-6th Ed | |||
6-10 years | 0.9 – 2.6 | JHU-Harriet Lane Ref.-6th Ed | |||
11-16 years | 0.9 – 3.4 | JHU-Harriet Lane Ref.-6th Ed |
Test | Age | Reference Range | Critical Values | Source | Comments |
---|---|---|---|---|---|
WBC, 103 cells/uL | 0-3 days | 7.0 – 25.7 | <2.0 and >40,000 103 cells/uL | Ugandan | Range verified locally |
4-60 days | 3.6 – 15.4 | Ugandan | |||
61-365 days | 2.5 – 17.8 | Ugandan | Range verified locally | ||
366-730 days | 3.6 – 16.4 | <2.0 and >20,000 103 cells/uL | Ugandan | Range verified locally | |
2-6 years | 5.0 – 15.5 | JHU-Harriet Lane Ref | |||
7-12 years | 4.5 – 13.5 | JHU-Harriet Lane Ref | |||
13-18 | 4.5 – 13.5 | JHU-Harriet Lane Ref | |||
RBC, 106 cells/uL | 0-3 days | 3.3 – 5.0 | None | Ped. Reference Range-2nd Ed (Coulter) | Range verified locally |
4-14 days | 3.5 – 5.3 | Ped. Reference Range-2nd Ed (Coulter) | |||
15-30 days | 3.3 – 4.9 | Ped. Reference Range-2nd Ed (Coulter) | |||
31-60 days | 3.1 – 4.1 | Ped. Reference Range-2nd Ed (Coulter) | |||
61-730 days | 3.4 – 5.2 | Ped. Reference Range-2nd Ed (Coulter) | Range verified locally | ||
2-12 years | 3.3 – 4.9 | Ped. Reference Range-2nd Ed (Coulter) | |||
13-18 years | 3.3 – 5.4 | Ped. Reference Range-2nd Ed (Coulter) | |||
HGB, g/dL | 0-3 days | 12.6 – 20.9 | <10.0 g/dL
|
Ugandan | |
4-7 days | 11.3 – 19.8 | Ugandan | |||
8-60 days | 8.1 – 13.2 | <7.0 g/dL | Ugandan | ||
61-730 days | 7.2 – 12.7 | Ugandan | Range verified locally | ||
2-6 years | 11.5 – 13.5 |
<9.0 HIV - <7.5 HIV + |
JHU-Harriet Lane Ref.-6th Ed | ||
7-12 years | 11.5 – 15.5 | JHU-Harriet Lane Ref.-6th Ed | |||
13-18 years | 12.0 – 16.0 | JHU-Harriet Lane Ref.-6th Ed | |||
HCT, % | 0-3 days | 45 – 67 |
None |
JHU-Harriet Lane Ref.-6th Ed | |
4-14 days | 41 – 65 | JHU-Harriet Lane Ref.-6th Ed | |||
15-30 days | 33 – 55 | JHU-Harriet Lane Ref.-6th Ed | |||
31-60 days | 28 – 42 | JHU-Harriet Lane Ref.-6th Ed | |||
61-180 days | 31 – 41 | JHU-Harriet Lane Ref.-6th Ed | |||
181-730 days | 33 – 39 | JHU-Harriet Lane Ref.-6th Ed | |||
2-6 years | 34 – 40 | JHU-Harriet Lane Ref.-6th Ed | |||
7-12 years | 35 – 45 | JHU-Harriet Lane Ref.-6th Ed | |||
13-18 years | 36 – 50 | JHU-Harriet Lane Ref.-6th Ed | |||
MCH, pg | 0-3 days | 31.3 – 38.6 |
None |
Ped. Reference Range-2nd Ed (Coulter) | |
4-14 days | 29.1 – 36.2 | Ped. Reference Range-2nd Ed (Coulter) | |||
15-30 days | 28.8 – 33.6 | Ped. Reference Range-2nd Ed (Coulter) | |||
31-60 days |
28.0 – 30.5 | Ped. Reference Range-2nd Ed (Coulter) | |||
61-730 days | 24.2 – 30.0 | Ped. Reference Range-2nd Ed (Coulter) | |||
2-12 years | 24.6 – 30.9 | Ped. Reference Range-2nd Ed (Coulter) | |||
13-18 years | 25.9 – 31.0 | Ped. Reference Range-2nd Ed (Coulter) | |||
MCHC, g/dL | 0-3 days | 29 – 37 |
None |
JHU-Harriet Lane Ref.-6th Ed | |
4-14 days | 28.1 – 34.7 | JHU-Harriet Lane Ref.-6th Ed | |||
15-30 days | 28.1 - 35.5 | JHU-Harriet Lane Ref.-6th Ed | |||
31-60 days | 28.3 – 35.3 | JHU-Harriet Lane Ref.-6th Ed | |||
61-180 days | 32.0 – 37.3 | JHU-Harriet Lane Ref.-6th Ed | |||
181-730 days | 30.0 – 36.0 | JHU-Harriet Lane Ref.-6th Ed | Range verified locally | ||
2-6 years | 31.0 – 37.0 | JHU-Harriet Lane Ref.-6th Ed | |||
7-12 years | 31.0 – 37.0 | JHU-Harriet Lane Ref.-6th Ed | |||
13-18 years | 31.0 – 37.0 | JHU-Harriet Lane Ref.-6th Ed | |||
RDW, % | 0-3 days | 14.9 – 18.5 | None | Ped. Reference Range-2nd Ed (Coulter) | |
4-14 days | 14.6 – 19.2 | Ped. Reference Range-2nd Ed (Coulter) | |||
15-30 days | 14.2 – 18.5 | Ped. Reference Range-2nd Ed (Coulter) | |||
31-60 days | 12.9 – 17.0 | Ped. Reference Range-2nd Ed (Coulter) | |||
61-730 days | 12.1 – 16.2 | Ped. Reference Range-2nd Ed (Coulter) | |||
2-12 years | 11.8 – 14.9 | Ped. Reference Range-2nd Ed (Coulter) | |||
13-18 years | 12.1 – 18.4 | Ped. Reference Range-2nd Ed (Coulter) | |||
PLT, 103 cells/uL | 0-3 days | 130 – 345 | <50 103 cells/uL | Ugandan | |
4-7 days | 135 – 460 | Ugandan | |||
8-90 days | 150 – 600 | Ugandan | |||
91-730 days | 140 – 635 | Ugandan | |||
2-6 years | 150 – 350 | JHU-Harriet Lane Ref.-6th Ed | |||
7-18 years | 150 – 350 | JHU-Harriet Lane Ref.-6th Ed | |||
MPV, fL | 0-3 days | 7.1 – 8.4 | None | Ped. Reference Range-2nd Ed (Coulter) | |
4-14 days | 7.5 – 10.0 | Ped. Reference Range-2nd Ed (Coulter) | |||
15-30 days | 8.0 – 10.6 | Ped. Reference Range-2nd Ed (Coulter) | |||
31-60 days | 7.0 – 11.3 | Ped. Reference Range-2nd Ed (Coulter) | |||
61-730 days | 6.8 – 9.3 | Ped. Reference Range-2nd Ed (Coulter) | |||
2-12 years | 7.1 – 9.4 | Ped. Reference Range-2nd Ed (Coulter) | |||
13-18 years | 7.3 – 9.7 | Ped. Reference Range-2nd Ed (Coulter) |
Test | Age | Reference Range | Critical Values | Source | Comments |
---|---|---|---|---|---|
NEUT % | 0-3 days | 33.9 – 69.6 | Critical values based on absolute cell counts | Ped. Reference Range-2nd Ed (Coulter) | |
4-14 days | 15.8 – 61.1 | Ped. Reference Range-2nd Ed (Coulter) | |||
15-30 days | 17.3 – 61.0 | Ped. Reference Range-2nd Ed (Coulter) | |||
31-60 days | 16.0 – 58.9 | Ped. Reference Range-2nd Ed (Coulter) | |||
61-730 days | 20.7 – 61.8 | Ped. Reference Range-2nd Ed (Coulter) | |||
2-12 years | 32.3 – 76.9 | Ped. Reference Range-2nd Ed (Coulter) | |||
13-18 years | 41.9 – 77.8 | Ped. Reference Range-2nd Ed (Coulter) | |||
LYMPH% | 0-3 days | 12 – 42 | Critical values based on absolute cell counts | Ugandan | |
4-60 days | 24 – 61 | Ugandan | |||
61-365 days | 32 – 80 | Ugandan | |||
366-735 days | 28 – 70 | Ugandan | |||
2-6 years | 14.3 – 50.6 | Ped. Reference Range-2nd Ed (Coulter) | |||
7-12 years | 13.1 – 45.2 | Ped. Reference Range-2nd Ed (Coulter) | |||
13-18 years | 12.9 – 40.6 | Ped. Reference Range-2nd Ed (Coulter) | |||
MONOS% | 0-3 days | 1.4 – 16.3 | Critical values based on absolute cell counts | Ped. Reference Range-2nd Ed (Coulter) | |
4-60 days | 1.3 – 22.2 | Ped. Reference Range-2nd Ed (Coulter) | |||
61-365 days | 2.7 – 22.9 | Ped. Reference Range-2nd Ed (Coulter) | |||
366-730 days | 2.4 – 19.1 | Ped. Reference Range-2nd Ed (Coulter) | |||
2-6 years | 3.3 – 18.1 | Ped. Reference Range-2nd Ed (Coulter) | |||
7-12 years | 13.1 – 45.2 | Ped. Reference Range-2nd Ed (Coulter) | |||
13-18 years | 12.9 – 40.6 | Ped. Reference Range-2nd Ed (Coulter) | |||
EOS% | 0-3 days | 0 – 2.9 | Critical values based on absolute cell counts | Ped. Reference Range-2nd Ed (Coulter) | |
4-14 days | 0 – 7.5 | Ped. Reference Range-2nd Ed (Coulter) | |||
15-30 days | 0 – 5.4 | Ped. Reference Range-2nd Ed (Coulter) | |||
31-60 days | 0 – 3.1 | Ped. Reference Range-2nd Ed (Coulter) | |||
61-730 days | 0 – 3.1 | Ped. Reference Range-2nd Ed (Coulter) | |||
2-12 years | 0 – 4.0 | Ped. Reference Range-2nd Ed (Coulter) | |||
13-18 years | 0 – 4.1 | Ped. Reference Range-2nd Ed (Coulter) | |||
BASO% | 0-3 days | 0 – 2.1 | Critical values based on absolute cell counts | Ped. Reference Range-2nd Ed (Coulter) | |
4-14 days | 0 – 2.7 | Ped. Reference Range-2nd Ed (Coulter) | |||
15-30 days | 0 – 1.1 | Ped. Reference Range-2nd Ed (Coulter) | |||
31-60 days | 0 – 0.9 | Ped. Reference Range-2nd Ed (Coulter) | |||
61-730 days | 0 – 1.1 | Ped. Reference Range-2nd Ed (Coulter) | |||
2-12 years | 0 – 1.1 | Ped. Reference Range-2nd Ed (Coulter) | |||
13-18 years | 0 – 1.0 | Ped. Reference Range-2nd Ed (Coulter) | |||
NEUT, 103 cells/uL | 0-1 days | 5.0 – 21.0 | <3.0 | JHU-Harriet Lane Ref.-6th Ed | |
2-7 days | 1.5 – 10.0 | <1.0 | JHU-Harriet Lane Ref.-6th Ed | ||
7-14 days | 1.0 – 9.5 | <0.75 | JHU-Harriet Lane Ref.-6th Ed | ||
14-30 days | 1.0 – 8.5 | JHU-Harriet Lane Ref.-6th Ed | |||
31-180 days | 1.0 – 8.5 | JHU-Harriet Lane Ref.-6th Ed | |||
181-730 days | 1.0 – 8.5 | JHU-Harriet Lane Ref.-6th Ed | |||
2-6 years | 1.5 – 8.0 | JHU-Harriet Lane Ref.-6th Ed | |||
7-10 years | 1.5 – 8.5 | JHU-Harriet Lane Ref.-6th Ed | |||
11-16 years | 1.8 – 8.0 | JHU-Harriet Lane Ref.-6th Ed | |||
LYMPH, 103 cells/uL | 0-3 days | 1.7 – 6.5 | <0.5 | Ugandan | |
4-60 days | 1.3 – 9.3 | Ugandan | |||
61-365 days | 1.0 – 10.6 | Ugandan | |||
366-730 days | 1.1 – 8.6 | Ugandan | |||
2-6 years | 1.5 – 7.0 | JHU-Harriet Lane Ref.-6th Ed | |||
6-12 years | 0.9 – 3.4 | JHU-Harriet Lane Ref.-6th Ed | |||
12-16 years | 1.2 – 5.2 | JHU-Harriet Lane Ref.-6th Ed | |||
MONO, 103 cells/uL | 0-3 days | 0.2 – 2.2 | None | Ped. Reference Range-2nd Ed (Coulter) | |
4-14 days | 0.1 – 2.9 | Ped. Reference Range-2nd Ed (Coulter) | |||
15-30 days | 0.2 – 5.0 | Ped. Reference Range-2nd Ed (Coulter) | |||
31-60 days | 0.2 – 2.1 | Ped. Reference Range-2nd Ed (Coulter) | |||
61-730 days | 0.3 – 1.9 | Ped. Reference Range-2nd Ed (Coulter) | |||
2-12 years | 0.4 – 1.1 | Ped. Reference Range-2nd Ed (Coulter) | |||
13-18 years | 0.4 – 0.9 | Ped. Reference Range-2nd Ed (Coulter) | |||
EOS, 103 cells/uL | 0-3 days | 0 – 0.2 | None | Ped. Reference Range-2nd Ed (Coulter) | |
4-14 days | 0 – 0.6 | Ped. Reference Range-2nd Ed (Coulter) | |||
15-30 days | 0 – 0.5 | Ped. Reference Range-2nd Ed (Coulter) | |||
31-60 days | 0 – 0.2 | Ped. Reference Range-2nd Ed (Coulter) | |||
61-730 days | 0 – 0.2 | Ped. Reference Range-2nd Ed (Coulter) | |||
2-12 years | 0 – 0.2 | Ped. Reference Range-2nd Ed (Coulter) | |||
13-18 years | 0 – 0.2 | Ped. Reference Range-2nd Ed (Coulter) | |||
BASO, 103 cells/uL | 0-3 days | 0 – 0.5 | None | Calculated Value/based on RR's Above | |
4-60 days | 0 – 0.4 | Calculated Value/based on RR's Above | |||
61-730 days | 0 – 0.2 | Calculated Value/based on RR's Above | |||
2-12 years | 0 – 0.2 | Calculated Value/based on RR's Above | |||
13-18 years | 0 – 0.1 | Calculated Value/based on RR's Above |
Test | Age | Reference Range | Critical Value | Source | Comments |
---|---|---|---|---|---|
Albumin, g/dL | 1-4 days | 2.8 – 4.4 g/dL | <2.0 g/dL | Roche.Ref.Manual | |
5 days - 14 yrs | 3.8 – 5.4 g/dL | Roche.Ref.Manual | |||
15-18 years | 3.2 – 4.5 g/dL | Roche.Ref.Manual | |||
Alk. Phosphatase, IU/L | 0-1 days | 0 – 250 U/L | To be determined | Roche.Ref.Manual | |
2-5 days | 0 – 231 U/L | Roche.Ref.Manual | |||
6-180 days | 0 – 449 U/L | Roche.Ref.Manual | |||
7-12 months | 0 – 462 U/L | Roche.Ref.Manual | |||
1-3 years | 0 – 281 U/L | Roche.Ref.Manual | |||
4-6 years | 0 – 269 U/L | Roche.Ref.Manual | |||
7-12 years | 0 – 300 U/L | Roche.Ref.Manual | |||
13-17 years (male) | 0 – 390 U/L | Roche.Ref.Manual | |||
13-17 years (female) | 0 – 187 U/L | Roche.Ref.Manual | |||
ALT (SGPT), U/L | 0-6 days | 0 – 57 U/L | >450 U/L | Ugandan | Range verified locally |
7-30 days | 0 – 45 U/L | Ugandan | |||
31-60 days | 5 – 55 U/L | Ugandan | |||
61-180 days | 0 – 60 U/L | Roche.Ref.Manual | Range verified locally | ||
7-12 months | 0 – 57 U/L | Roche.Ref.Manual | Range verified locally | ||
1-3 years | 0 – 39 U/L | >390 U/L | Roche.Ref.Manual | Range verified locally | |
4-6 years | 0 – 39 U/L | Roche.Ref.Manual | |||
7-12 years | 0 – 39 U/L | Roche.Ref.Manual | |||
13-17 year (male) | 0 – 26 U/L | >230 U/L | Roche.Ref.Manual | ||
13-17 year (female) | 0 – 23 U/L | Roche.Ref.Manual | |||
AST (SGOT), U/L | 0-1 day | 0 – 122 U/L | >1100U/L | Roche.Ref.Manual | |
2-5 days | 0 – 110 U/L | Roche.Ref.Manual | |||
6-180 days | 0 – 84 U/L | >840 U/L | Roche.Ref.Manual | ||
7-12 months | 0 – 89 U/L | Roche.Ref.Manual | |||
1-3 year | 0 – 56 U/L | >510 U/L | Roche.Ref.Manual | ||
4-6 year | 0 – 52 U/L | Roche.Ref.Manual | |||
7-12 year | 0 – 51 U/L | Roche.Ref.Manual | |||
13-17 year (male) | 0 – 35 U/L | >270 U/L | Roche.Ref.Manual | ||
13-17 year (female) | 0 – 27 U/L | Roche.Ref.Manual | |||
Amylase (AMY) | 0-1 years | 0 – 8 U/L | To be determined | Roche.Ref.Manual | |
1-9 years | 0 – 31 U/L | Roche.Ref.Manual | |||
10-18 years | 0 – 39 U/L | Roche.Ref.Manual | |||
Creatine Kinase (CK) | 1 day | 0 – 712 U/L | To be determined | Roche.Ref.Manual | |
2-5 days | 0 – 652 U/L | Roche.Ref.Manual | |||
6-180 days | 0 – 295 U/L | Roche.Ref.Manual | |||
7-12 months | 0 – 203 U/L | Roche.Ref.Manual | |||
1-3 years | 0 – 228 U/L | Roche.Ref.Manual | |||
4-6 years | 0 – 149 U/L | Roche.Ref.Manual | |||
7-12 years (male) | 0 – 247 U/L | Roche.Ref.Manual | |||
7-12 years (female) | 0 – 154 U/L | Roche.Ref.Manual | |||
13-17 years (male) | 0 – 270 U/L | Roche.Ref.Manual | |||
13-17 years (female) | 0 – 123 U/L | Roche.Ref.Manual | |||
Creatinine, mg/dL | 0-1 days | 0 – 0.98 mg/dL | To be determined | Roche.Ref.Manual | |
2-14 days | 0 – 0.88 mg/dL | Roche.Ref.Manual
|
|||
15-59 days | 0 – 0.70 mg/dL | MU-JHU PI's Medical Committee | |||
2-12 months | 0 – 0.39 mg/dL | Roche.Ref.Manual | |||
1-3 years | 0 – 0.35 mg/dL | Roche.Ref.Manual | |||
4-5 years | 0 – 0.42 mg/dL | Roche.Ref.Manual | |||
6-7 years | 0 – 0.47 mg/dL | Roche.Ref.Manual | |||
8-9 years | 0 – 0.53 mg/dL | Roche.Ref.Manual | |||
10-11 years | 0 – 0.64 mg/dL | Roche.Ref.Manual | |||
12-13 years | 0 – 0.68 mg/dL | Roche.Ref.Manual | |||
14-15 years | 0 – 0.77 mg/dL | Roche.Ref.Manual | |||
Glucose, mg/dL | 1-5 days | 50 – 80 mg/dL | To be determined | Roche.Ref.Manual | |
6-365 days | 42 – 96 mg/dL | MU-JHU PI's Medical Committee | |||
1-2 years | 33 – 111 mg/dL | Roche.Ref.Manual | |||
3-4 years | 52 – 98 mg/dL | Roche.Ref.Manual | |||
5-6 years | 69 – 100 mg/dL | Roche.Ref.Manual | |||
GGT, U/L | 0-1 days | 0 – 151 U/L | To be determined | Roche.Ref.Manual | |
2-5 days | 0 – 185 U/L | Roche.Ref.Manual | |||
6-180 days | 0 – 204 U/L | Roche.Ref.Manual | |||
7-12 monts | 0 – 34 U/L | Roche.Ref.Manual | |||
1-3 years | 0 – 18 U/L | Roche.Ref.Manual | |||
4-6 years | 0 – 23 U/L | Roche.Ref.Manual | |||
7-12 years | 0 – 17 U/L | Roche.Ref.Manual | |||
13-17 years (male) | 0 – 45 U/L | Roche.Ref.Manual | |||
13-17 years (female) | 0 – 33 U/L | Roche.Ref.Manual | |||
Ura nitrogen, mg/dL (BUN) | 0-6 months | 0 – 42 mg/dL | To be determined | Roche.Ref.Manual | |
0.5-18 years | 0 – 48 mg/dL | Roche.Ref.Manual | |||
Total Bilirubin | 0-3 days | 0 – 6.0 mg/dL | To be determined | Ugandan | |
4-7 days | 0 – 12.9 mg/dL | Ugandan | |||
8-60 days | 0 – 2.1 mg/dL | Ugandan | |||
61 days-18 years | 0 – 1.0 mg/dL | Roche.Ref.Manual | |||
Uric Acid (UA) | 0-1 days | 0 – 5.5 mg/dL | To be determined | Roche.Ref.Manual | |
2-28 days | 0 – 5.2 mg/dL | Roche.Ref.Manual | |||
1-12 months | 0 – 6.2 mg/dL | Roche.Ref.Manual | |||
1-18 years | 0 – 6.1 mg/dL | Roche.Ref.Manual | |||
Electrolytes | |||||
Chloride (CL) | 0-1 days | 97 –122 mmol/L | To be determined | Roche.Ref.Manual | |
2-28 days | 95 –116 mmol/L | Roche.Ref.Manual | |||
1-12 months | 93 –112 mmol/L | Roche.Ref.Manual | |||
1-18 years | 96 –111 mmol/L | Roche.Ref.Manual | |||
Potassium (K) | 0-1 days | 3.2 – 4.6 mmol/L | To be determined | Roche.Ref.Manual | |
2-28 days | 3.6 – 6.1 mmol/L | Roche.Ref.Manual | |||
1-12 months | 3.6 – 5.8 mmol/L | Roche.Ref.Manual | |||
1-18 years | 3.1 – 5.1 mmol/L | Roche.Ref.Manual | |||
Sodium (Na) | 0-1 days | 128 – 147 mmol/L | To be determined | Roche.Ref.Manual | |
2-28 days | 132 – 147 mmol/L | Roche.Ref.Manual | |||
1-12 months | 129 – 143 mmol/L | Roche.Ref.Manual | |||
1-18 years | 132 – 145 mmol/L | Roche.Ref.Manual |